E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2016 in the Prospect News Convertibles Daily and Prospect News Liability Management Daily.

HeartWare: Holders may put or convert 3.5%, 1.75% notes after merger

By Susanna Moon

Chicago, June 27 – HeartWare International, Inc. said holders will be able to put or convert its 3.5% convertible senior notes due 2017 and its 1.75% convertible senior notes due 2021 as a result of its planned merger.

The company has entered into a merger agreement on June 27 with Medtronic, Inc., which will constitute a fundamental change, according to an 8-K filing with the Securities and Exchange Commission.

HeartWare is a medical device company located in Framingham, Mass., and Sydney, Australia. Medtronic is a medical technology company based in Minneapolis.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.